Lee CK - Search Results

1

Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs.

Lee CK, Kim S, Lee JS, Lee JE, Kim SM, Yang IS, Kim HR, Lee JH, Kim S, Cho BC. Lee CK, et al. Among authors: lee js, lee je, lee jh. Lung Cancer. 2017 Nov;113:106-114. doi: 10.1016/j.lungcan.2017.09.005. Epub 2017 Sep 12. Lung Cancer. 2017. PMID: 29110836

2

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine.

Lee CK, Jung M, Choi HJ, Kim HR, Kim HS, Roh MR, Ahn JB, Chung HC, Heo SJ, Rha SY, Shin SJ. Lee CK, et al. Cancer Res Treat. 2015 Oct;47(4):781-9. doi: 10.4143/crt.2014.261. Epub 2015 Feb 16. Cancer Res Treat. 2015. PMID: 25687848 Free PMC article. Clinical Trial.

3

The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.

Chon HJ, Kim HR, Shin E, Kim C, Heo SJ, Lee CK, Park JK, Noh SH, Chung HC, Rha SY. Chon HJ, et al. Among authors: lee ck. Ann Surg Oncol. 2015 Nov;22(12):3938-45. doi: 10.1245/s10434-015-4376-8. Epub 2015 Feb 24. Ann Surg Oncol. 2015. PMID: 25707491

4

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.

Heo SJ, Jung I, Lee CK, Kim JH, Lim SM, Moon YW, Shim HS, Jeong J, Kim JH, Kim HR, Cho BC. Heo SJ, et al. Among authors: lee ck. Cancer Chemother Pharmacol. 2016 Mar;77(3):539-48. doi: 10.1007/s00280-016-2968-z. Epub 2016 Jan 25. Cancer Chemother Pharmacol. 2016. PMID: 26811178 Clinical Trial.

5

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Ahn BC, Lee JH, Kim MH, Pyo KH, Lee CK, Lim SM, Kim HR, Cho BC, Hong MH. Ahn BC, et al. Among authors: lee ck, lee jh. Cancers (Basel). 2021 Jun 21;13(12):3096. doi: 10.3390/cancers13123096. Cancers (Basel). 2021. PMID: 34205733 Free PMC article.

6

Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer.

Lee CK, Lee ME, Lee WS, Kim JM, Park KH, Kim TS, Lee KY, Ahn JB, Chung HC, Rha SY. Lee CK, et al. Among authors: lee me, lee ws, lee ky. Am J Cancer Res. 2014 Dec 15;5(1):72-86. eCollection 2015. Am J Cancer Res. 2014. PMID: 25628921 Free PMC article.

7

Correlation Analysis and Prognostic Impact of (18)F-FDG PET and Excision Repair Cross-Complementation Group 1 (ERCC-1) Expression in Non-Small Cell Lung Cancer.

Jeong YH, Lee CK, Jo K, Hwang SH, Cha J, Lee JW, Yun M, Cho A. Jeong YH, et al. Among authors: lee ck, lee jw. Nucl Med Mol Imaging. 2015 Jun;49(2):108-14. doi: 10.1007/s13139-014-0304-2. Epub 2014 Nov 8. Nucl Med Mol Imaging. 2015. PMID: 26085855 Free PMC article.

8

The prognostic value of volume-based parameters using ¹⁸F-FDG PET/CT in gastric cancer according to HER2 status.

Park JS, Lee N, Beom SH, Kim HS, Lee CK, Rha SY, Chung HC, Yun M, Cho A, Jung M. Park JS, et al. Among authors: lee ck, lee n. Gastric Cancer. 2018 Mar;21(2):213-224. doi: 10.1007/s10120-017-0739-0. Epub 2017 Jun 22. Gastric Cancer. 2018. PMID: 28643145

9

Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses.

Yoon JG, Kim MH, Jang M, Kim H, Hwang HK, Kang CM, Lee WJ, Kang B, Lee CK, Lee MG, Chung HC, Choi HJ, Park YN. Yoon JG, et al. Among authors: lee ck, lee mg, lee wj. Hepatology. 2021 Oct;74(4):1914-1931. doi: 10.1002/hep.31862. Epub 2021 Jul 29. Hepatology. 2021. PMID: 33884649

10

Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma.

Park E, Yoo JE, Hwang HK, Kang CM, Lee CK, Kim MH, Bang S, Park YN. Park E, et al. Among authors: lee ck. J Hepatobiliary Pancreat Sci. 2022 Feb;29(2):250-261. doi: 10.1002/jhbp.1025. Epub 2021 Aug 17. J Hepatobiliary Pancreat Sci. 2022. PMID: 34318617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,291 results

Search Page

Filters